Back

TTR's vital role throughout the body

29 August 2025 (10:09 - 10:17)
Organised by: Logo
Congress Presentation Part of: The importance of transthyretin (TTR): optimising outcomes in ATTRv-CM and ATTRwt-CM Cardiac Amyloidosis Open Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Morie A Gertz

Mayo Clinic, Rochester (United States of America)

4 More presentations in this session

Presentation thumbnail
Introduction
Professor M. Fontana (London, GB)
Presentation thumbnail
TTR stabilisation for the management of variant and Wild-Type ATTR-CM
Doctor N. Sarswat (Chicago, US)
Presentation thumbnail
Clinical impact of early TTR stabilisation
Doctor A. Masri (Portland, US)
Presentation thumbnail
Q&A

Access the full session

Session thumbnail
The importance of transthyretin (TTR): optimising outcomes in ATTRv-CM and ATTRwt-CM

The Event

Event poster

ESC Congress 2025

29 August 2025 10:09 CET
You may be interested in
thumbnail
Congress Presentation
The role of TTR as a surrogate marker in treatment of ATTR-CM
2 September 2024
thumbnail
Congress Presentation
Cracking the code: the biology and mechanism of CETP inhibition
29 August 2025
thumbnail
Webinar
New drugs in the treatment of amyloidosis
16 July 2025
thumbnail
Congress Presentation
Lactate-mediated GATA6 degradation exacerbates thoracic aortic aneurysm/dissection through formation of proinflammatory vascular smooth muscle cells via annexin A1 pathway
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources